abstract |
A novel vascular endothelial growth factor is provided. A human VEGF-2 antibody, a human VEGF-2 antibody fragment, or a variant thereof is disclosed. A process for producing such antibodies is also provided. The present invention relates to methods and compositions for preventing, treating, or ameliorating a disease or disorder, wherein the method is directed to an animal, preferably a human, in an effective amount of one or more VEGF-2 antibodies or VEGF- Administering two antibody fragments or variants thereof. In one embodiment, the primary antibody of the present invention is a monoclonal antibody. [Selection figure] None |